Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/172072
Treatment of multiple myeloma with renal involvement: the nephrologist's view
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Renal injury is a common complication in multiple myeloma (MM). In fact, as many as 10% of patients with MM develop dialysis-dependent acute kidney injury related to increased free light chain (FLC) production by a plasma cell clone. Myeloma cast nephropathy (MCN) is the most prevalent pathologic diagnosis associated with renal injury, followed by light chain deposition disease and light chain amyloidosis. Several FLC removal techniques have been explored to improve kidney disease in MM but their impact on renal clinical outcomes remains unclear. According to the evidence, high cut-off haemodialysis should be restricted to MM patients on chemotherapy with histological diagnosis of MCN and haemodialysis requirements. From our perspective, more efforts are needed to improve kidney outcomes in patients with MM and renal failure.
Subject
Subject (English)
Citation
Citation
FAVÀ BUCH, Alexandre, et al. Treatment of multiple myeloma with renal involvement: the nephrologist's view. Clinical Kidney Journal. 2018. Vol. 11, num. 6, pags. 777-785. ISSN 2048-8505. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/172072